Suchergebnisse - "Lipka, Daniel B"

PubPharm (5)

1

MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers

enthalten in: Molecular oncology | 2022

von Niger, M. | Nichetti, F. | Casadei-Gardini, A. | +30

2

Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial

enthalten in: Blood advances | 2021

von Niemeyer, C. | Flotho, C. | Lipka, D. | +22

3

Combining CNN-based histologic whole slide image analysis and patient data to improve skin cancer classification

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Höhn, J. | Krieghoff-Henning, E. | Jutzi, T. | +28

4

RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia

enthalten in: Nature communications | 2017

von Lipka, D. | Witte, T. | Toth, R. | +37

5

Addition of rituximab to standard therapy improves response rate and progression-free survival in relapsed or refractory thrombotic thrombocytopenic purpura and autoimmune haemolytic anaemia

enthalten in: Thrombosis and haemostasis | 2007

von Heidel, F. | Lipka, D. | von Auer, C. | +3

1
[1]